Literature DB >> 27272329

[Posterior reversible encephalopathy syndrome].

M Fischer1, E Schmutzhard2.   

Abstract

Posterior reversible encephalopathy syndrome refers to a neurological disorder characterized by headache, disorders of consciousness, visual disturbances, epileptic seizures, and subcortical vasogenic edema. About two thirds of patients develop neurological symptoms, which are associated with blood pressure fluctuations. One hypothesis is that hypertensive episodes cause autoregulatory failure, and values above the upper limit of cerebral autoregulation result in a breakthrough followed by hyperperfusion and blood-brain barrier dysfunction. In another hypothesis, endothelial dysfunction triggered by numerous factors including preeclampsia, immunosuppressive agents, chemotherapeutics, sepsis, or autoimmune disorders is thought to be the key pathomechanism. Endo- or exogenic toxic agents including pharmacological substances, cytokines, or bacterial toxins are supposed to trigger endothelial activation and dysfunction resulting in the release of vasoconstrictors, pro-inflammatory mediators, and vascular leakage. Diagnosis is usually based on clinical and neuroimaging findings that frequently show a bilateral, symmetric, and parietooccipital pattern. However, the diagnosis can often only be confirmed during the course of disease after excluding important differential diagnoses. Currently, there is no specific treatment available. Lowering of arterial blood pressure and eliminating the underlying cause usually leads to an improvement of clinical and neuroradiological findings. Admission to a critical care unit is required in about 40 % of patients due to complicating conditions including status epilepticus, cerebral vasoconstriction, ischemia, or intracerebral hemorrhage. Prognosis is favorable; in the majority of patients neurological deficits and imaging findings resolve completely.

Entities:  

Keywords:  Autoimmune diseases; Chemotherapy; Hypertensive encephalopathy; Imaging; Pre-eclampsia

Mesh:

Substances:

Year:  2016        PMID: 27272329     DOI: 10.1007/s00063-016-0175-7

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  30 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

2.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

Authors:  Jennifer E Fugate; Daniel O Claassen; Harry J Cloft; David F Kallmes; Osman S Kozak; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

3.  Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging.

Authors:  A M McKinney; B Sarikaya; C Gustafson; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

4.  Posterior reversible encephalopathy syndrome: the endothelial hypotheses.

Authors:  A Marra; M Vargas; P Striano; L Del Guercio; P Buonanno; G Servillo
Journal:  Med Hypotheses       Date:  2014-03-01       Impact factor: 1.538

5.  Posterior reversible encephalopathy syndrome with spinal cord involvement.

Authors:  Adam de Havenon; Zachary Joos; Loren Longenecker; Lubdha Shah; Safdar Ansari; Kathleen Digre
Journal:  Neurology       Date:  2014-10-29       Impact factor: 9.910

Review 6.  Posterior reversible encephalopathy syndrome: a review.

Authors:  Steven K Feske
Journal:  Semin Neurol       Date:  2011-05-17       Impact factor: 3.420

Review 7.  PRES in Children Undergoing Hematopoietic Stem Cell or Solid Organ Transplantation.

Authors:  Riccardo Masetti; Duccio Maria Cordelli; Daniele Zama; Francesca Vendemini; Carlotta Biagi; Emilio Franzoni; Andrea Pession
Journal:  Pediatrics       Date:  2015-05       Impact factor: 7.124

Review 8.  Posterior reversible encephalopathy syndrome.

Authors:  C Lamy; C Oppenheim; J L Mas
Journal:  Handb Clin Neurol       Date:  2014

9.  Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene.

Authors:  Atsushi Yamauchi; Ichiro Ieiri; Yasufumi Kataoka; Mizuho Tanabe; Takashi Nishizaki; Ryozo Oishi; Shun Higuchi; Kenji Otsubo; Keizo Sugimachi
Journal:  Transplantation       Date:  2002-08-27       Impact factor: 4.939

Review 10.  Long-term consequences of the posterior reversible encephalopathy syndrome in eclampsia and preeclampsia: a review of the obstetric and nonobstetric literature.

Authors:  Ineke R Postma; Sjoerdtje Slager; Hubertus P H Kremer; Jan Cees de Groot; Gerda G Zeeman
Journal:  Obstet Gynecol Surv       Date:  2014-05       Impact factor: 2.347

View more
  8 in total

1.  Posterior reversible encephalopathy syndrome (PRES) as a complication of Guillain-Barre' syndrome (GBS).

Authors:  Sumaira Nabi; Haris Majid Rajput; Mazhar Badshah; Shahzad Ahmed
Journal:  BMJ Case Rep       Date:  2016-08-03

2.  The Prevalence and Impact of Status Epilepticus Secondary to Intracerebral Hemorrhage: Results from the US Nationwide Inpatient Sample.

Authors:  Amol Mehta; Benjamin E Zusman; Lori A Shutter; Ravi Choxi; Ahmed Yassin; Arun Antony; Parthasarathy D Thirumala
Journal:  Neurocrit Care       Date:  2018-06       Impact factor: 3.210

3.  [Prolonged reversible cortical blindness over 5 days after cardiac catheterization].

Authors:  H Wedekind; M Özgün
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-12-20       Impact factor: 0.840

4.  An Atypical Syndrome in an Elderly Patient With Systemic Lupus Erythematosus, Sjögren Syndrome, and Primary Biliary Cirrhosis.

Authors:  Xiaojuan Song; Xia Rong; Yi Liu
Journal:  Arch Rheumatol       Date:  2017-02-23       Impact factor: 1.472

5.  Posterior Reversible Encephalopathy Syndrome and Azathioprine.

Authors:  Sara Vilas-Boas; Ana Corte-Real
Journal:  Eur J Case Rep Intern Med       Date:  2019-01-25

Review 6.  [Toxic changes of the central nervous system].

Authors:  W Reith; A Haußmann
Journal:  Radiologe       Date:  2018-12       Impact factor: 0.635

7.  Posterior reversible encephalopathy syndrome induced by food poisoning in a pediatric patient: a case report.

Authors:  Xue-Mei Wu; Guang-Liang Wang; Chang-Gui Kou; Jiang-Tao Wang; Jian-Min Liang; Ya-Qin Yu
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

8.  Initial Normotensive Presentation of a Primigravida With Posterior Reversible Encephalopathy Syndrome: A Case Report.

Authors:  Angelica Aduen-Carrillo; Maria Jose Hernandez-Woodbine; Camilo A Avendaño-Capriles; Francisco N Ayola-Anaya
Journal:  Cureus       Date:  2021-11-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.